AMRN, S, YGE, CDI, - CRWESelect.com Stock News! Amarin Corporation plc, Sprint Nextel Corp., Yingli Green Energy Holding Co. Ltd., CDI Corp. (Video Included Inside)

FOR IMMEDIATE RELEASE
Las Vegas, Nevada, United States of America (Free-Press-Release.com) November 26, 2011 -- To view video, and read the full article visit URL http://crweselect.com/27524/stock-alerts/amrn-s-yge-cdi-crweselectcom-stock-news-amarin-corporation-plc-sprint-nextel-corp-yingli-green-energy-holding-co-ltd-cdi-corp-video-included-inside/

Amarin Corporation plc (NASDAQ:AMRN)

AMRN, recently announced that its New Drug Application (NDA) for AMR101 has been accepted for filing by the U.S. Food and Drug Administration (FDA). The acceptance of the NDA reflects the FDA’s determination that the application is sufficiently complete to permit a substantive review.

AMR101 is a prescription-grade omega-3 fatty acid, comprising not less than 96% ultra pure EPA (icosapent ethyl), that Amarin is developing for the treatment of patients with very high triglyceride levels (>=500 mg/dL) and as a potentially first-in-class therapy for patients with high triglyceride levels (>=200 and =500 mg/dL]), as reported in November 2010, and the ANCHOR trial (investigation of AMR101 for the treatment of patients on statin therapy with high triglycerides [>=200 and <500mg/dL] with mixed dyslipidemia), as reported in April 2011. Both the MARINE and ANCHOR trials were conducted under Special Protocol Assessment (SPA) agreements with the U.S. Food and Drug Administration (FDA). Amarin also has next-generation lipid candidates under evaluation for preclinical development. In September 2011, Amarin submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the marketing and sale of AMR101 for treatment of the patient population studied in the MARINE trial. Amarin plans to separately seek approval for the population studied in the ANCHOR trial after its REDUCE-IT cardiovascular outcomes trial is substantially underway. In August 2011, an SPA agreement with the FDA was reached for the REDUCE-IT cardiovascular outcomes study. The Company seeks to have this study substantially underway before the end of 2012.

For more inormation about AMRN please visit http://www.amarincorp.com

****

Sprint Nextel Corp. (NYSE:S) Chief Financial Officer Joe Euteneuer will participate in the Bank of America Merrill Lynch 2011 Leveraged Finance Conference in Orlando, FL on Thursday, Dec. 1 at 10:50 a.m. Eastern Time. Euteneuer will answer questions during a “fireside chat.” A live audio webcast of this session may be accessed Dec. 1 at www.sprint.com/investors. The replay of the presentation will be available shortly after the actual presentation time.

Sprint Nextel Corporation, through its subsidiaries, offers wireless and wireline communications products and services to individual consumers, businesses, government subscribers, and resellers in the United States, Puerto Rico, and the U.S. Virgin Islands.

****

Yingli Green Energy Holding Co. Ltd. (NYSE:YGE) previously announced its unaudited consolidated financial results for the quarter ended September 30, 2011. Total net revenues were RMB 4,258.6 million ( US$667.7 million ). PV module shipment increased by 21.9% from the second quarter of 2011, reaching another historical high. Total net revenues were RMB 4,258.6 million ( US$667.7 million ) in the third quarter of 2011, compared to RMB 4,398.8 million in the second quarter of 2011 and RMB 3,284.2 million in the third quarter of 2010. The slight decrease in total net revenues quarter over quarter was due to the decline of average selling price, partially offset by increased PV module shipment that was attributable to diversified customer portfolio geographically.

Yingli Green Energy Holding Company Limited, together with its subsidiaries, engages in the design, development, manufacture, marketing, sale, and installation of photovoltaic (PV) products in the Peoples Republic of China and internationally.

****

CDI Corp. (NYSE:CDI) announced that it will conduct a live webcast at 10:00 a.m. Eastern Time on December 8, 2011 , to provide results of the Company's strategic review. Hosting the call will be CDI's president & chief executive officer, Paulett Eberhart . Also participating will be Robert Larney , executive vice president & chief financial officer, Philip Clark , executive vice president of Global Business Development & Operations, and Robert Giorgio , president of CDI's Engineering Solutions division.

CDI Corp. provides engineering and information technology project outsourcing solutions and professional staffing services primarily in the United States, the United Kingdom, and Canada. It operates in four segments.

To read the full article visit URL http://crweselect.com/27524/stock-alerts/amrn-s-yge-cdi-crweselectcom-stock-news-amarin-corporation-plc-sprint-nextel-corp-yingli-green-energy-holding-co-ltd-cdi-corp-video-included-inside/

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer/) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

AMRNcrweselect1126

Amarin Corporation     AMR101     AMRN     CDI     CDI Corp.     Sprint Nextel     Yingli Green Energy